Status:
ENROLLING_BY_INVITATION
Idiopathic Diseases of Man
Lead Sponsor:
Scripps Translational Science Institute
Conditions:
Rare Disease
Idiopathic Disease
Eligibility:
All Genders
Brief Summary
This research is being done to learn more about possible genetic causes of currently undiagnosed conditions, and to find out how the development of new technologies, such as DNA sequencing, can increa...
Eligibility Criteria
Inclusion
- Individual with rare disorder with previous unknown etiology.
- Individual with known disorder that does not respond to conventional treatment.
- Individual experienced a rare adverse event that was a result of the administration of a pharmacologic or biologic agent, immunization or device.
- Individual is a family member of the affected individual. -
Exclusion
- Unwilling or unable to grant informed consent if they do not have a legal guardian who has authority to sign a consent form on their behalf.
- Have a significant medical, affective, or psychiatric condition that in the Investigator's opinion may interfere with subject's study participation.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01440218
Start Date
September 1 2011
End Date
December 1 2030
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scripps Translational Science Institute
La Jolla, California, United States, 92037